Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?

U Frei, K. M. Koch(Medizinische Hochschule Hannover), D. Wieters(Medizinische Hochschule Hannover), R. Brunkhorst(Klinikum Region Hannover), Ulrich Grouven(Medizinische Hochschule Hannover), Ralf Schindler(Charité - Universitätsmedizin Berlin)

Nephrology Dialysis Transplantation

July 1, 1995

10.1093/ndt/10.7.1206

Cited by 81

Related Papers

Epidemiology of sepsis in Germany: results from a national prospective multicenter study

|Intensive Care Medicine|2007|623

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

|BMJ|2012|309

First Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients

|Journal of the American Society of Nephrology|2002|274

Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized study

|Arthritis & Rheumatism|1998|261

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

|Nephrology Dialysis Transplantation|2012|239